Medindia

X

Mirus Bio Releases for Sale TransIT(R)-2020; a New Broad Spectrum, Animal-Free Transfection Reagent to Go Head to Head With FuGENE(R) HD and Lipofectamine(TM) 2000

Thursday, September 17, 2009 General News J E 4
Advertisement
MADISON, Wis., Sept. 8 From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:

Visit www.mirusbio.com for all your transfection needs including data, protocols, technical support or to place an order.

The Transfection Experts

For over a decade, Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.

-- Superior Performance--TransIT(R)-2020 outperforms FuGENE(R) HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types. -- Broad Spectrum DNA Delivery--Achieve high transgene expression in many cell types, including hard to transfect cells. -- Animal Origin free-- TransIT(R)-2020 provides high performance with maximum compatibility. -- Scientifically Proven--Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.

SOURCE Mirus Bio LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
BioTrends Research Group is Recognized by the Phil...
S
FDA pharmaceutical import alert